China Biotech In Review: Mindray Medical Reports Another Record-Breaking Year Seeking Alpha OrbiMed Advisors is raising money for its second Asia healthcare private equity fund, which will be invested mainly in China and India. In news reports this week, the target was pegged at $500 million, though sources close ... Pfizer (NYSE: PFE ... |
